Genetic Testing Enhancing Ovarian Cancer Diagnosis
Genetic testing for BRCA1, BRCA2, and other hereditary genes has become integral to ovarian cancer diagnostics. Identifying at-risk individuals allows for preventive measures and personalized treatment options.
Next-generation sequencing and other molecular diagnostic techniques enable comprehensive genetic profiling. These tools support clinicians in early detection, targeted therapy planning, and monitoring disease progression. As testing becomes more affordable and accessible, adoption rates are rising globally.
For further insights, refer to the Ovarian Cancer Diagnostics Market analysis.
9 Views